BIO KEY INTERNATIONAL INC
Close on Oct 19, 2026
- Market cap
- $2.35M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 13, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 14, 2026 | Before market open | $1.92M | $-0.56 | – |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 20, 2026 | Before market open | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 4, 2026 | Before market open | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 14, 2025 | Before market open | $1.55M | $-0.15 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | Before market open | $1.70M | $-0.20 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | After market close | $1.61M | $-0.16 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 27, 2025 | Before market open | $1.46M | $-0.53 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 15, 2024 | Before market open | $2.10M | $-0.39 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 15, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 2, 2024 | Before market open | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Oct 25, 2023 | During market hours | – | – | – |
Company guidance
Outlook given with results on Apr 20, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| revenues | 1H’26 | $5.00M | New |
| revenues expected to grow | 1H’26 | 50% growth | New |
| revenues | Q2’26 | $2.80M | New |
| revenues expected to grow | Q2’26 | 65% growth | New |
| revenues | Q1’26 | $2.20M | New |
| revenues expected to grow | Q1’26 | 37% growth | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Bio Key International filed with the SEC
BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally;
Results of operations · EX-99.1 to Form 8-K
BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading resumes on Wednesday, July 8th
Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue;
Results of operations · EX-99.1 to Form 8-K
BIO-key Shares Expected to Temporarily Move to OTC ™ Markets Tomorrow, Wednesday May 13 th
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Following Stockholder Approval, BIO-key Announces 1-for-10 Reverse Stock Split
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the Period
Results of operations · EX-99.1 to Form 8-K
BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET
Results of operations · EX-99.1 to Form 8-K
Retail Bank Executes Expanded $1.04M License Renewal for BIO-key
Results of operations · EX-99.1 to Form 8-K
Digital Identity and Biometric Access Management Provider BIO-key Reports Q3 Results;
Results of operations · EX-99.1 to Form 8-K
BIO-key Q2 ’ 25 Revenue Rose 49% Driven by Increases
Results of operations · EX-99.1 to Form 8-K
BIO-key Reports Q1 ’ 25 Revenue of $1.6M and Improved Cash Position of $3.1M;
Results of operations · Listing notice · EX-99.1 to Form 8-K
BIO-key Regains Compliance with Nasdaq Listing Rules
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower
Results of operations · EX-99.1 to Form 8-K
BIO-key and Fiber Food Systems Inc. Collaborate to Enhance Security and Efficiency in the Food Tech Sector
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key Reports Q3 ’ 24 Revenue Rose 18% to $2.1M, Reduced Q3 ’ 24 Net Loss, and
Results of operations · EX-99.1 to Form 8-K
BIO-key International Enters into $1.9 Million Warrant Inducement
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2 ’ 24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET
Results of operations · EX-99.1 to Form 8-K
Identity and Access Management Software Provider BIO-key Reports Q1 ’ 24 Revenue of $2.2M and Positive Operating Cash Flow; Hosts Investor Call Tuesday, 10am ET
Results of operations · EX-99.1 to Form 8-K
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
Listing notice · Prior financials no longer reliable · Regulation FD disclosure · EX-99.1 to Form 8-K
Identity and Access Management Software Provider BIO-key Preliminary 2023 Results:
Results of operations · EX-99.1 to Form 8-K
BIO-key Repays $2.2M Senior Secured Note
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Following Stockholder Approval, BIO-key Announces 1-for-18 Reverse Stock Split
Executive or director change · Charter or bylaw amendment · Shareholder vote results · Other events · EX-99.1 to Form 8-K
BIO-key International Announces Pricing of $3.75 Million Public Offering
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key International Announces Closing of $3.75 Million Public Offering
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
Digital Authentication and Identity Provider BIO-key Sees Q3 Revenues Rising over 30% to $1.8M on Strength in Software License Fees, Services and Hardware Sales
Results of operations · EX-99.1 to Form 8-K
Identity and Access Management Provider BIO-key Reports Q2 Revenue of $1.9M;
Results of operations · EX-99.1 to Form 8-K
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Identity and Access Management Provider BIO-key ’ s Q1 Revenue Rose 59% Driven by Growing Recurring Revenue Base and New Customer Wins; Investor Call 10am ET Today
Results of operations · EX-99.1 to Form 8-K
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Cybersecurity Solutions Provider BIO-key ’ s 2022 Revenues Increased 37% to $7.0M
Results of operations · EX-99.1 to Form 8-K
Cyber-Security Provider BIO-key Reports Q3 and Year-to-Date Revenues Rose to $1.4M and $5.3M, Respectively, on Growing Software and Services Revenue;
Results of operations · EX-99.1 to Form 8-K
BIO-key Completes Acquisition of Swivel Secure Europe, Significantly Expanding its Revenue Base, Customer Reach and Talent in Europe, Middle East and Africa
Material agreement · Acquisition or disposition completed · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
BIO-key to Significantly Expand Customer Reach and Talent in EMEA Region via
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K